Oruka Therapeutics, Inc. (ORKA) — Cash Flow-to-Debt Ratio
Oruka Therapeutics, Inc. (ORKA) has a Cash Flow-to-Debt Ratio of -0.96x as of September 2025, meaning its operating cash flow of $-21.60 Million could theoretically repay -1% of its total liabilities ($22.46 Million) in one year. See ORKA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oruka Therapeutics, Inc. Cash Flow-to-Debt Ratio (2005–2024)
Historical debt coverage capacity for Oruka Therapeutics, Inc. across 19 annual periods. Also explore ORKA shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Oruka Therapeutics, Inc. (2005–2024)
Year-by-year debt coverage analysis for Oruka Therapeutics, Inc.. For market capitalisation and broader financial context, see Oruka Therapeutics, Inc. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.19x | $-57.84 Million | $13.80 Million | ▲ +45.8% |
| 2022 | -7.73x | $-10.91 Million | $1.41 Million | ▼ -59.9% |
| 2021 | -4.83x | $-18.76 Million | $3.88 Million | ▼ -144.6% |
| 2020 | -1.98x | $-7.72 Million | $3.91 Million | ▲ +61.9% |
| 2019 | -5.18x | $-4.80 Million | $926.00K | ▲ +50.1% |
| 2018 | -10.40x | $-8.24 Million | $793.00K | ▼ -24.4% |
| 2017 | -8.36x | $-17.47 Million | $2.09 Million | ▼ -35.8% |
| 2016 | -6.15x | $-14.99 Million | $2.44 Million | ▲ +12.1% |
| 2015 | -7.00x | $-10.53 Million | $1.50 Million | ▼ -3.6% |
| 2014 | -6.76x | $-9.41 Million | $1.39 Million | ▼ -92.2% |
| 2013 | -3.52x | $-5.29 Million | $1.50 Million | ▲ +73.7% |
| 2012 | -13.37x | $-4.08 Million | $305.00K | ▼ -47.9% |
| 2011 | -9.04x | $-6.96 Million | $770.00K | ▼ -50.4% |
| 2010 | -6.01x | $-8.32 Million | $1.39 Million | ▲ +71.8% |
| 2009 | -21.29x | $-41.73 Million | $1.96 Million | ▼ -1796.4% |
| 2008 | -1.12x | $-18.40 Million | $16.39 Million | ▼ -29.5% |
| 2007 | -0.87x | $-45.96 Million | $53.02 Million | ▼ -167.9% |
| 2006 | -0.32x | $-37.06 Million | $114.56 Million | ▲ +71.9% |
| 2005 | -1.15x | $-59.03 Million | $51.28 Million | — |